| Structure |
Chemical Name |
CAS |
MF |
 |
BRD4770 |
1374601-40-7 |
C25H23N3O3 |
 |
MI-3 (Menin-MLL Inhibitor) |
1271738-59-0 |
C18H25N5S2 |
 |
BIX 01294 |
1392399-03-9 |
C28H41Cl3N6O2 |
 |
K-Ras inhibitor |
1469338-01-9 |
C20H30ClN3O2S3 |
 |
SBE 13 hydrochloride |
1052532-15-6 |
C24H28Cl2N2O4 |
 |
Ferrostatin-1 (Fer-1) |
347174-05-4 |
C15H22N2O2 |
 |
FTI 277 HYDROCHLORIDE |
180977-34-8 |
C22H30ClN3O3S2 |
 |
LB 42708 |
226929-39-1 |
C30H27BrN4O2 |
 |
Deltarasin |
1440898-61-2 |
C40H37N5O |
 |
GSK-2110183C |
1047644-62-1 |
C18H17Cl2FN4OS |
 |
AKT Kinase Inhibitor |
842148-40-7 |
C16H19N7O3 |
 |
IEM 1754 dihydrobroMide |
162831-31-4 |
C16H32Br2N2 |
 |
Dizocilpine |
77086-21-6 |
C16H15N |
 |
WAY100635 |
1092679-51-0 |
C29H38N4O6 |
 |
AZD 2932 |
883986-34-3 |
C24H25N5O4 |
 |
LDC1267 |
1361030-48-9 |
C30H26F2N4O5 |
 |
GZD 824 |
1257628-77-5 |
C29H27F3N6O |
 |
SR2516 |
1061353-68-1 |
C25H26F3N5O3 |
 |
KN-93 Phosphate |
1188890-41-6 |
C26H32ClN2O8PS |
 |
EPZ015666 |
1616391-65-1 |
C20H25N5O3 |
 |
HYDROXYGUANIDINE SULFATE |
6345-29-5 |
C2H12N6O6S |
 |
N-(4-Mesitylthiazol-2-yl)benzaMide |
1001753-24-7 |
C19H18N2OS |
 |
NMS-P937 (NMS1286937) |
1034616-18-6 |
C24H27F3N8O3 |
![3-aMino-5-chloro-N-cyclopropyl-4-Methyl-6-(2-(4-Methylpiperazin-1-yl)-2-oxoethoxy)thieno[2,3-b]pyridine-2-carboxaMide](/CAS/20150408/GIF/886047-22-9.gif) |
3-aMino-5-chloro-N-cyclopropyl-4-Methyl-6-(2-(4-Methylpiperazin-1-yl)-2-oxoethoxy)thieno[2,3-b]pyridine-2-carboxaMide |
886047-22-9 |
C19H24ClN5O3S |
 |
OF-1 |
919973-83-4 |
C17H18BrN3O4S |
 |
Liproxstatin-1 |
950455-15-9 |
C19H21ClN4 |
 |
1-(4-(2-((4-chloro-2-hydroxy-5-iodophenyl)aMino)acetyl)piperazin-1-yl)prop-2-en-1-one |
1469337-95-8 |
C15H17ClIN3O3 |
 |
4SC-202 (free base) |
910462-43-0 |
C23H21N5O3S |
 |
K-Ras(G12C) inhibitor 6 |
2060530-16-5 |
C17H22Cl2N2O3S |
 |
SRT2104 (GSK2245840) |
1093403-33-8 |
C26H24N6O2S2 |
 |
K-Ras(G12C) inhibitor 9 |
1469337-91-4 |
C16H21ClIN3O4S |
![5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide](/CAS/20180629/GIF/1253584-84-7.gif) |
5-[2,4-Dihydroxy-6-(4-nitrophenoxy)phenyl]-N-(1-methyl-4-piperidinyl)-3-isoxazolecarboxamide |
1253584-84-7 |
C22H22N4O7 |
 |
MPI-0479605 |
1246529-32-7 |
C22H29N7O |
![PD 125,530, trans-(±)-3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol hydrochloride](/CAS/GIF/112960-16-4.gif) |
PD 125,530, trans-(±)-3,4,4a,10b-Tetrahydro-4-propyl-2H,5H-[1]benzopyrano[4,3-b]-1,4-oxazin-9-ol hydrochloride |
112960-16-4 |
C14H19NO3.ClH |
![4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide](/CAS/20150408/GIF/953769-46-5.gif) |
4-((2-(((1R,2R)-2-hydroxycyclohexyl)aMino)benzo[d]thiazol-6-yl)oxy)-N-MethylpicolinaMide |
953769-46-5 |
C20H22N4O3S |
 |
Piperazine, 1-diphenylmethyl-4-methyl-, dihydrochloride |
5897-18-7 |
C18H24Cl2N2 |
 |
WHI-P97 |
211555-05-4 |
C16H13Br2N3O3 |
 |
PRX-08066 |
866206-55-5 |
C23H21ClFN5O4S |
 |
LY-2584702 (tosylate salt) |
1082949-68-5 |
C28H27F4N7O3S |
 |
BMX-IN-1 |
1431525-23-3 |
C29H24N4O4S |
 |
UM729 |
1448723-60-1 |
C20H25N5O2 |
 |
TAI-1 |
1334921-03-7 |
C24H21N3O3S |
 |
Cyclophosphamide-d4 |
173547-45-0 |
C7H15Cl2N2O2P |
 |
ML 141 |
71203-35-5 |
C22H21N3O3S |
 |
KP372-1 |
329710-24-9 |
C10H4N6O |
 |
ML234 |
1222800-79-4 |
C21H23N3O2 |
 |
Nafamostat mesylate |
|
|
 |
115007-34-6 |
115007-34-6 |
|
![BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]-](/CAS/20150408/GIF/1186206-79-0.gif) |
BenzaMide, N-[4-[(4-ethyl-1-piperazinyl)Methyl]-3-(trifluoroMethyl)phenyl]-4-Methyl-3-[[[5-(2-thienyl)-3-pyridinyl]carbonyl]aMino]- |
1186206-79-0 |
C32H32F3N5O2S |
![2H-IMidazole-2-thione, 5-(aMinoMethyl)-1-[(2R)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-,](/CAS/20150408/GIF/195881-94-8.gif) |
2H-IMidazole-2-thione, 5-(aMinoMethyl)-1-[(2R)-5,7-difluoro-1,2,3,4-tetrahydro-2-naphthalenyl]-1,3-dihydro-, |
195881-94-8 |
C14H16ClF2N3S |
 |
HPOB |
1429651-50-2 |
C17H18N2O4 |
 |
BRD73954 |
1440209-96-0 |
C16H16N2O3 |
![5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine](/CAS/20150408/GIF/1394076-92-6.gif) |
5-(6-(3-Methoxyoxetan-3-yl)-4-Morpholinothieno[3,2-d]pyriMidin-2-yl)pyriMidin-2-aMine |
1394076-92-6 |
C19H22N6O3S |
 |
MHY1485 |
326914-06-1 |
C17H21N7O4 |
 |
Debio-1347 |
1265229-25-1 |
C20H16N6O |
 |
(R)-2-((R)-2-acetamido-3-(4-hydroxyphenyl)propanamido)-N-((R)-1-amino-1-oxo-3-phenylpropan-2-yl)-5-guanidinopentanamide |
1809784-29-9 |
C26H35N7O5 |
![(S)-2-(8-(2-(6-(methylamino)pyridin-2-yl)ethoxy)-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl)acetic acid](/CAS/20180629/GIF/205678-31-5.gif) |
(S)-2-(8-(2-(6-(methylamino)pyridin-2-yl)ethoxy)-3-oxo-2-(2,2,2-trifluoroethyl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-4-yl)acetic acid |
205678-31-5 |
C22H24F3N3O4 |
|
|
PF-562271HCl |
|
C21H21ClF3N7O3S |
 |
EW-7197 |
1352608-82-2 |
C22H18FN7 |
 |
SAR405838 (MI-773) |
1303607-60-4 |
C29H34Cl2FN3O3 |
 |
LY2409881 trihydrochloride |
946518-60-1 |
C24H30Cl2N6OS |
 |
(±)-2-(tert-Butylamino)-3'-chlorpropiophenonhydrochlorid |
31677-93-7 |
C13H19Cl2NO |
 |
Cerdulatinib HCl salt |
1369761-01-2 |
C20H28ClN7O3S |
 |
UMI-77 |
518303-20-3 |
C18H14BrNO5S2 |
 |
HIV-1 integrase inhibitor |
544467-07-4 |
C11H9N3O4 |
 |
CX6258(HCL) |
1353859-00-3 |
C26H25Cl2N3O3 |
 |
GSK 2830371 |
1404456-53-6 |
C23H29ClN4O2S |
 |
ME0328 |
1445251-22-8 |
C19H19N3O2 |
![1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, hydrochloride (1:1)](/CAS/20180808/GIF/198480-56-7.gif) |
1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-, hydrochloride (1:1) |
198480-56-7 |
C30H35ClN2O3 |
 |
Ethyl dimorpholine |
|
C10H20N2O2 |
![4-ThiazolecarboxaMide, N-(6-benzoyl-1H-benziMidazol-2-yl)-2-(1-thieno[3,2-d]pyriMidin-4-yl-4-piperidinyl)-](/CAS/GIF/913822-46-5.gif) |
4-ThiazolecarboxaMide, N-(6-benzoyl-1H-benziMidazol-2-yl)-2-(1-thieno[3,2-d]pyriMidin-4-yl-4-piperidinyl)- |
913822-46-5 |
C29H23N7O2S2 |